March 6, 2015
Based on HKBIO 1st Discussion Forum, HKBIO had identified and chosen 3 particular areas (i.e. Medical Devices, TCM and Clinical Trials) to be discussed further at its 2nd Discussion forum among representatives from the top management from different government bodies; and other local scientists, innovators, researchers and industry leaders in the field to join and provide valuable suggestions for the development of the 3 particular biotech subsectors mentioned above:
Hong Kong Biotechnology Organization (HKBIO)
Prof Christopher Cheng (Executive Vice Chairman)
*Prof Michael Yang (Vice Chairman)
Mr Allen Ma (Council Member)
Dr Natalie Chow (Secretariat)
Ms Erica To (Secretariat)
Innovation and Technology Commission (ITC)
Dr Theobald Chan (Senior Biotechnology Officer)
Dr Yin F. Mak (Senior Biotechnology Officer)
InvestHK
Mr Charles Ng (Associate Director-General 2)
Hong Kong Science & Technology Park Corporation (HKSTPC)
Dr Daniel Lee (Head of Biotech Cluster)
Hong Kong Medical and Healthcare Devices Industries Association (HKMHDIA)
Ir Prof Andros Chan (Chairman)
Mr Benjamin Chan (Deputy Chairman)
*Ms Martha Hao (Vice Chairman)
Modernized Chinese Medicine International Association (MCMIA)
*Dr Albert Wong (Founding President)
Dr Vivian Taam Wong (Chief Executive)
Mr Sammy Tse (Regulatory Affairs & Research Coordinator)
Faculty of Medicine, Chinese University of Hong Kong
*Prof Juliana Chan (Chair Professor, Department of Medicine and Therapeutics)
Prof Charing Chong (Assistant Professor and Specialist in General Surgery, Division of Hepato-biliary and Pancreatic Surgery)
Prof Zhixin Lin (Associate Professor, School of Chinese Medicine)
Dr Chan Kam Leung (Academic Development Manager, Hong Kong Institute of Integrative Medicine)
Dr Wendy Wong (Assistant Professor, Hong Kong Institute of Integrative Medicine)
Dr Risa Ozaki (Medical Director of Clinical Research Management Office and Phase 1 Clinical Trial Centre)
Ms Jessica Ching (Associate Director R&D, Hong Kong Institute of Integrative Medicine)
Ms Cheong Pui Kwan (Senior Research Assistant, Hong Kong Institute of Integrative Medicine)
Ms Kay Yuen (Research Associate, Hong Kong Institute of Integrative Medicine)
Ms Chan Ho Yan (Teaching Assistant, Hong Kong Institute of Integrative Medicine)
Ms Iris Chan (Managing Director, Clinical Research Management Office and Phase 1 Clinical Trial Centre)
Nano and Advanced Materials Institute Limited (NAMI)
Mr Him Pan (Engineer)
Mr Alexander Ip (Engineer)
Zigen Pharmaceutical Limited
*Dr Albert Wong (Managing Director)
AgaMatrix Hong Kong Limited
Mr Andrew Lee (General Manager)
Ms SC Lim (Quality Director)
Nordson Medical
Mr Sam Chiu (Regional Director)
Oxyvital International Limited
Mr Daniel Hau (Sales & Business Development Director)
Ms Jade Chan (Marketing Director)
Kerry Pharma (Hong Kong) Limited
Mr Samuel Tong (Deputy General Manager)
Winner Medical Group
Mr Kevin Orr (Managing Director)
*Session Chair
